site stats

Ctxr sec filings

WebCommon stock, $0.001 par value CTXR The Nasdaq Capital Market  Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ WebJan 15, 2013 · Ticker: CTXR CIK: 1506251 Form Type: 10-K Annual Report Accession Number: 0001185185-13-000090 Submitted to the SEC: Tue Jan 15 2013 1:09:25 PM EST Accepted by the SEC: Tue Jan 15 2013 Period: Sunday, September 30, 2012 Industry: Pharmaceutical Preparations External Resources: Stock Quote Social Media Bookmark …

Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly …

WebCitius Pharmaceuticals, Inc. Common Stock (CTXR) SEC Filings Nasdaq SEC Filings: CTXR Edit my quotes Citius Pharmaceuticals, Inc. Common Stock (CTXR) 0 Add to Watchlist Add to... WebApr 3, 2024 · Ticker: CTXR CIK: 1506251 Form Type: 8-K Corporate News Accession Number: 0001213900-23-026265 Submitted to the SEC: Mon Apr 03 2024 4:05:20 PM … chip\u0027s cw https://tlcky.net

Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly …

WebFeb 8, 2024 · NASDAQ CTXR opened at $1.42 on Wednesday. Citius Pharmaceuticals, Inc. has a 12 month low of $0.77 and a 12 month high of $2.01. The firm has a market capitalization of $207.62 million, a PE ratio of -6.45 and a beta of 1.41. The company's 50 day simple moving average is $1.11 and its 200 day simple moving average is $1.13. WebFeb 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly report for the period ending Thursday, December 31, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu Feb 11 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. WebBack to CTXR Overview Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note: An FPI is exempt... graphic card compatibility checker online

SG Americas Securities LLC Takes $108,000 Position in Citius ...

Category:Citius Pharmaceuticals, Inc. (CTXR) - Yahoo!

Tags:Ctxr sec filings

Ctxr sec filings

CTXR Short Interest Ratio and Volume (Citius Pharmaceuticals) …

WebDec 22, 2024 · SEC Filings Citius Pharmaceuticals, Inc. (CTXR) 8-K Material Event Thu Dec 22 2024 Earnings Press Release 8-K Corporate News Citius Pharmaceuticals, Inc. … WebThese reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Citius Pharmaceuticals Inc

Ctxr sec filings

Did you know?

WebFind the latest SEC Filings data for Citius Pharmaceuticals, Inc. Common Stock (CTXR) at Nasdaq.com. Citius Pharmaceuticals, Inc. Common Stock (CTXR) SEC Filings …

WebJan 9, 2024 · Filings & Forms. All companies, foreign and domestic, are required to file registration statements, periodic reports, and other forms electronically through EDGAR. … WebNov 15, 2024 · Contact Us. Citius Pharmaceuticals, Inc. 11 Commerce Drive, First Floor Cranford, NJ 07016 908-967-6677 [email protected]. follow us on twitter

WebCTXR / Citius Pharmaceuticals Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5 EXTENDED Overview Owners Insiders Short Interest Options Filings Financials … WebAug 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Thursday, June 30, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu Aug 11 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades.

WebFeb 10, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Saturday, December 31, 2024

WebAt Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. chip\u0027s dbWebCTXR Institutional Holdings Ownership Summary Active Positions New and Sold Out Positions 88 Institutional Holders 15,192,898 Total Shares Held Back to CTXR Overview Institutional Holdings... chip\u0027s ctWebFind the latest Citius Pharmaceuticals, Inc. (CTXR) stock quote, history, news and other vital information to help you with your stock trading and investing. chip\u0027s composition on my three sonsWebAug 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Thursday, June 30, 2024 chip\u0027s czWebDec 12, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 8-K Material Event for the period ending Tuesday, December 11, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 8-K Material Event Wed Dec 12 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. chip\u0027s dcWebSep 28, 2024 · Ticker: CTXR CIK: 1506251 Form Type: 8-K Corporate News Accession Number: 0001213900-22-059746 Submitted to the SEC: Wed Sep 28 2024 4:05:14 PM EST Accepted by the SEC: Wed Sep 28 2024 Period: Wednesday, September 28, 2024 Industry: Pharmaceutical Preparations Events: Financial Exhibit; Other Events; External … graphic card computerWebSEC Filings for Citius Pharmaceuticals Inc (CTXR) including Annual 10-K and Quarterly 10-Q Reports. Your browser of choice has not been tested for use with Barchart.com. If … chip\u0027s cy